UNITED LABORATORIES

About TUL

Founded in 1990, TUL is one of China’s leading integrated pharmaceutical companies, principally engaged in the R&D, manufacturing, and sales of pharmaceutical products. Currently, TUL is a constituent stock of the Hang Seng Composite Index Series, with an AA-grade MSCI ESG rating, ranking among the industry leaders.

Learn More

1990: Established

2007: Listed

18000 +: Total Employees

3933 .HK: Stock Code

13.211 billion: 2025 Revenue

1990: Established

2007: Listed

18000 +: Total Employees

3933 .HK: Stock Code

13.211 billion: 2025 Revenue

TUL Highlights

Learn More

: APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION

2026-07-15

: APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS

2026-07-03

Tsoi Hoi Shan Attended Novo Nordisk Roundtable to Discuss the Global Impact of Chinese Innovation

2026-06-22

Finished Products

Comprehensive Health Products

APIs and Intermediates

Animal protection products

Empty capsule

Medical device

Cosmetic Peptide Series

Finished Products

Comprehensive Health Products

APIs and Intermediates

Animal protection products

Empty capsule

Medical device

Cosmetic Peptide Series

Sales Network

TUL has a global sales network that spans over 70 countries and regions,
including China, Europe, India, the Middle East,
Africa, South America, and Southeast Asia.